Inventiva (IVEVF) Non-Current Deffered Revenue (2018 - 2025)
Inventiva (IVEVF) posted Non-Current Deffered Revenue of $146669.5 for Q4 2025, up 2.83% on a QoQ basis from $142626.9 in Q2 2025, and up 28.28% year-over-year from $114339.7 in Q4 2024.
Analysis
Inventiva (IVEVF) Non-Current Deffered Revenue (2018 - 2025) Analysis & Trends
Inventiva has reported Non-Current Deffered Revenue for 5 years, with the latest figure at $146669.5 in Q4 2025.
- On a quarterly basis, Non-Current Deffered Revenue rose 28.28% year-over-year to $146669.5 in Q4 2025; TTM through Dec 2025 was $146669.5, a 28.28% increase from a year earlier, with the FY2025 full-year figure at $146669.5, up 28.28% from the prior year.
- Non-Current Deffered Revenue was $146669.5 for Q4 2025 at Inventiva, up from $142626.9 in the prior quarter.
- The five-year high for Non-Current Deffered Revenue was $146669.5 in Q4 2025, with the low at $56113.6 in Q4 2022.
- Average Non-Current Deffered Revenue over 4 years is $100248.3, with a median of $94827.8 recorded in 2023.
- The sharpest annual moves came in 2024 and 2025: Non-Current Deffered Revenue soared 51.81% in 2024, then advanced 28.28% in 2025.
- Over 4 years, Non-Current Deffered Revenue stood at $56113.6 in 2022, then surged by 34.22% to $75315.8 in 2023, then soared by 51.81% to $114339.7 in 2024, then advanced by 28.28% to $146669.5 in 2025.
- The last three Non-Current Deffered Revenue figures came in at $146669.5 (Q4 2025), $142626.9 (Q2 2025), and $114339.7 (Q4 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.53 Bn | 625.77 Bn | 17.26 Bn | - |
| 2 | AbbVie | 442.27 Bn | 435.70 Bn | 12.70 Bn | - |
| 3 | Merck | 366.81 Bn | 359.67 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.82 Bn | 259.13 Bn | 11.24 Bn | - |
| 5 | Pfizer | 159.37 Bn | 147.67 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.46 Bn | 45.08 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 44.12 Bn | 44.12 Bn | - | - |
| 8 | Incyte | 25.49 Bn | 20.95 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.55 Bn | 18.89 Bn | 683.80 Mn | - |
| 10 | Inventiva | 693.72 Mn | 693.72 Mn | - | 146,669.48 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 146,669.48 |
| Jun 30, 2025 | 142,626.92 |
| Dec 31, 2024 | 114,339.71 |
| Dec 31, 2023 | 75,315.79 |
| Jun 30, 2023 | 66,424.39 |
| Dec 31, 2022 | 56,113.61 |
| Dec 31, 2018 | 1.91 Mn |